Clinical Trials in Nashville

Showing 10981-11000 of 17,403 trials

A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)

NCT01490866

This is a non-randomized, open-label, Phase II trial investigating axitinib as a single-agent maintenance therapy following standard first-line FOLFOX/bevacizumab therapy for patients with mCRC.

Colorectal Cancer

SCRI Development Innovations, LLC70 participantsStarted Jan 2012

Jonesboro, Arkansas, United States • Fort Myers, Florida, United States • Pensacola, Florida, United States +9 more locations

COMPLETED< 1 mile

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

NCT01281293

Vagus Nerve Stimulation (VNS) Therapy has been approved marked for the treatment of epilepsy since 1994. This post-market study is designed to follow the clinical course and outcomes for patients with refractory seizures treated with adjunctive VNS Therapy. Seizure frequency, seizure severity, side effects burden, depressive symptoms, global impressions, and health care utilization will be evaluated. The results of this study will provide data to guide physicians and their patients in the use of VNS Therapy for patients with refractory seizures who have failed initial trials of anti-epileptic drug (AED) therapy. The data being collected is not for the purposes of confirmatory assessment.

Epilepsy

Cyberonics, Inc.124 participantsStarted Jan 2011

Atlanta, Georgia, United States • Peoria, Illinois, United States • Louisville, Kentucky, United States +17 more locations

A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Find Trials by Condition in Nashville

Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934

A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Tissue Sarcoma

A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants

Pembrolizumab in Treating Patients With Advanced Uveal Melanoma

A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)

A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma

Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women

A Study of LY3015014 in Participants With High Cholesterol

A Study in Non-Small Cell Lung Cancer

A Study in Moderate to Severe Rheumatoid Arthritis Participants

Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome

Soft Contacts Observation of Risk and Education (SCORE)

MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer

A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer

1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids

A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus

A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes